<DOC>
	<DOCNO>NCT00946946</DOCNO>
	<brief_summary>This study aim compare azathioprine versus mesalazine tablet prevention clinical relapse postoperative Crohn 's disease ( CD ) patient moderate severe endoscopic recurrence .</brief_summary>
	<brief_title>Preventing Postoperative Relapse Crohn 's Disease Patients Risk : Azathioprine Versus Mesalazine</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Signed informed consent , Man woman 18 70 year age , Diagnosis Crohn 's disease confirm endoscopic histological , endoscopic radiological criterion within one year histopathological criterion resection , Clinical remission define Crohn´s Disease Activity Index ( CDAI ) &lt; 200 , within last two week . No clinical relapse due Crohn 's disease since resection , Moderate ( i2a ) severe endoscopic recurrence ( i3i4 ) within 6 24 month curative resection terminal ileum partial colectomy ileocolonic resection complication ileal Crohn´s disease construction ileocolonic anastomosis , Within neoterminal ileum least 5 aphthous lesion normal mucosa lesion , skip area large lesion , Negative pregnancy test screen visit female childbearing potential , Use appropriate contraceptive method females childbearing potential male procreative capacity treatment least 3 month end treatment . Lesions confine ileocolonic anastomosis ( i.e. , &lt; 1 cm length ) Short bowel syndrome , Serious secondary illness acute chronic nature , opinion Investigator render patient unsuitable inclusion study , Serum creatinine level exceed 1.5 mg/dL 130 umol/L , Presence ileo/colonic stoma , Genotype : thiopurine methyltransferase ( TPMT ) / , Known previous concurrent malignancy ( consider surgically cure , evidence recurrence 5 year ) , Treatment cytostatics immunosuppressant , methotrexate , cyclosporine , 6MP , Azathioprine , 6TG antiTFNalpha therapy since resection ; postoperative treatment corticosteroid 4 week postoperative treatment oral antibiotic ( e.g. , metronidazole , ciprofloxacin ) 4 week , Application nonsteroidal antiinflammatory drug ( NSAIDS ) within 2 week Screening visit except low dose acetylsalicylic acid except paracetamol , Known intolerance/hypersensitivity study drug drug similar chemical structure pharmacological profile , Scheduled intend active immunisation living vaccine within next 12 month , Wellfounded doubt patient 's cooperation , Existing pregnancy , lactation , intend pregnancy impregnation within next 15 month , Nonuse appropriate contraceptive male procreative capacity female childbearing potential ( e.g . condom male , intrauterine device [ IUD ] , hormonal contraception female , mean contraception particular patient consider adequate responsible investigator ) treatment within 3 month end treatment , Participation another clinical trial within last 30 day , simultaneous participation another clinical trial , previous participation trial , Present stricture plasty ( exclusion present stricture plasty macroscopically without relevant find inflammation see index surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Randomized</keyword>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Prevention</keyword>
	<keyword>Azathioprine</keyword>
	<keyword>mesalazine</keyword>
	<keyword>mesalamine</keyword>
	<keyword>TPMT</keyword>
</DOC>